Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06691074

Cavo-Tricuspid Isthmus Block Durability After Pulsed Electric Field Ablation

Led by Institute for Clinical and Experimental Medicine · Updated on 2024-11-15

150

Participants Needed

1

Research Sites

67 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study seeks to assess the acute durability of the CTI block when PEF energy is used. Second goal is to establish the optimal waiting time for the conduction recovery after PEF CTI ablation and to assess the utility of routine adenosine testing for dormant conduction. Moreover, this study aims to investigate the differences in acute efficacy and adverse events (hemolysis, coronary vasospasm) between the two available configurations (basket or flower) of the pentaspline Farawave catheter (Farapulse-Boston Scientific Inc, USA).

CONDITIONS

Official Title

Cavo-Tricuspid Isthmus Block Durability After Pulsed Electric Field Ablation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation by pulsed electric field energy with documented typical atrial flutter or patients with persistent atrial fibrillation planned for CTI ablation as part of a complex procedure
  • Age 18 years or older at study enrollment
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Left atrial diameter greater than 65 mm (measured in parasternal long-axis view)
  • History of cavo-tricuspid isthmus ablation
  • History of cardiac valve surgery
  • Significant valvular defect
  • Age below 18 years
  • Pregnancy or breastfeeding
  • Any disease with life expectancy less than 1 year
  • Uncorrected congenital heart disease or valvular obstruction
  • Active myocarditis
  • Untreated hypothyroidism or hyperthyroidism
  • Recipient of major organ transplant (lung, liver, heart)
  • HIV positivity with survival expectancy less than 5 years due to HIV
  • Chronic dialysis treatment
  • Unwillingness to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institute for Clinical and Experimental Medicine

Prague, Prague, Czechia, 14200

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here